On February 27, 2024, the company amended the terms of the transaction. Bionano Genomics, Inc., closed the transaction.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.678 USD | -7.69% | -9.60% | -64.13% |
06-20 | Bionano Genomics Says Revvity to Commercialize VIA Software | MT |
05-28 | Bionano Genomics Raises $18 Million From Private Debentures Placement | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-64.13% | 50.76M | |
+4.18% | 210B | |
+8.00% | 186B | |
+31.86% | 158B | |
+33.21% | 113B | |
+2.28% | 66.13B | |
+21.14% | 56.25B | |
+0.11% | 49B | |
-6.76% | 38.16B | |
+0.78% | 35.98B |
- Stock Market
- Equities
- BNGO Stock
- News Bionano Genomics, Inc.
- Bionano Genomics, Inc. announced that it has received $35 million in funding